Published On May 19, 2017
May.19 -- Bluebird Bio CEO Nick Leschly discusses gene therapy, Boston's biotech scene, and venture capital with Bloomberg's Caroline Hyde on "Bloomberg Technology" at the Museum of Science in Boston on May 9.
Please select the category that most closely reflects your concern about the video, so that we can review it and determine whether it violates our Community Guidelines or isn't appropriate for all viewers. Abusing this feature is also a violation of the Community Guidelines, so don't do it. firstname.lastname@example.org